Your browser doesn't support javascript.
Prevalence of indications for adult hepatitis A vaccination among hepatitis A outbreak-associated cases, Three US States, 2016-2019.
Hofmeister, Megan G; Weng, Mark K; Thoroughman, Douglas; Thomasson, Erica D; McBee, Shannon; Foster, Monique A; Collins, Jim; Burkholder, Cole; Augustine, Ryan J; Spradling, Philip R.
  • Hofmeister MG; Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: lxn7@cdc.gov.
  • Weng MK; Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Thoroughman D; Kentucky Department for Public Health, Frankfort, KY, United States; Career Epidemiology Field Officer Program, Division of State and Local Readiness, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Thomasson ED; Career Epidemiology Field Officer Program, Division of State and Local Readiness, Centers for Disease Control and Prevention, Atlanta, GA, United States; Bureau for Public Health, West Virginia Department of Health and Human Resources, Charleston, WV, United States.
  • McBee S; Bureau for Public Health, West Virginia Department of Health and Human Resources, Charleston, WV, United States.
  • Foster MA; Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Collins J; Division of Communicable Diseases, Michigan Department of Health and Human Services, Lansing, MI, United States.
  • Burkholder C; Division of Communicable Diseases, Michigan Department of Health and Human Services, Lansing, MI, United States.
  • Augustine RJ; Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Spradling PR; Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Vaccine ; 39(44): 6460-6463, 2021 10 22.
Article in English | MEDLINE | ID: covidwho-1466953
ABSTRACT

BACKGROUND:

Safe and effective hepatitis A vaccines have been recommended in the United States for at-risk adults since 1996; however, adult vaccination coverage is low.

METHODS:

Among a random sample of adult outbreak-associated hepatitis A cases from three states that were heavily affected by person-to-person hepatitis A outbreaks, we assessed the presence of documented Advisory Committee on Immunization Practices (ACIP) indications for hepatitis A vaccination, hepatitis A vaccination status, and whether cases that were epidemiologically linked to an outbreak-associated hepatitis A case had received postexposure prophylaxis (PEP).

RESULTS:

Overall, 74.1% of cases had a documented ACIP indication for hepatitis A vaccination. Fewer than 20% of epidemiologically linked cases received PEP.

CONCLUSIONS:

Efforts are needed to increase provider awareness of and adherence to ACIP childhood and adult hepatitis A vaccination and PEP recommendations in order to stop the current person-to-person hepatitis A outbreaks and prevent similar outbreaks in the future.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Hepatitis A Type of study: Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Adult / Child / Humans Country/Region as subject: North America Language: English Journal: Vaccine Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Hepatitis A Type of study: Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Adult / Child / Humans Country/Region as subject: North America Language: English Journal: Vaccine Year: 2021 Document Type: Article